#engineering — Tuesday, April 21, 2026 (1 items)
| 0 | 💬 0 |
Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8(+) T cell immunity via rewiring MHC-I antigen presentation.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-04-21 | #immunity #cancer #immunotherapy #engineering #oncolytic |